ILA 39980.0
(0.63%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 13.28 Billion | 14.15 Billion | 11.54 Billion | 7.93 Billion | 12.69 Billion | 14.1 Billion |
Cost of Revenue | 10.97 Billion | 11.82 Billion | 9.94 Billion | 6.85 Billion | 11.09 Billion | 12.24 Billion |
Gross Profit | 2.31 Billion | 2.33 Billion | 1.6 Billion | 1.08 Billion | 1.6 Billion | 1.86 Billion |
Operating Expenses | 1.78 Billion | 1.7 Billion | 1.2 Billion | 1.07 Billion | 1.13 Billion | 1.13 Billion |
Selling, General and Administrative Expenses | 417 Million | 457 Million | 388 Million | 327 Million | 347 Million | 343 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 22 Million | 2 Million | 11 Million | 2 Million | -17 Million | 4 Million |
Cost and Expenses | 12.75 Billion | 13.52 Billion | 11.14 Billion | 7.92 Billion | 12.22 Billion | 13.37 Billion |
Operating Income | 589 Million | 701 Million | 477 Million | -327 Million | -103 Million | 734 Million |
Interest Expense | 228 Million | 229 Million | 171 Million | 130 Million | 146 Million | 159 Million |
Income Tax Expense | 71 Million | -18 Million | 67 Million | -42 Million | 35 Million | 106 Million |
Earnings before Tax | 404 Million | 448 Million | 290 Million | -408 Million | -227 Million | 510 Million |
Net Income | -5 Million | 300 Million | 224 Million | -366 Million | -262 Million | 401 Million |
Earnings Per Share Basic | -0.47 | 28.20 | 23.50 | -36.55 | -25.75 | 39.46 |
Earnings Per Share Diluted | -0.45 | 26.50 | 22.60 | -36.55 | -25.72 | 39.40 |
Weighted Average Shares Outstanding | 10.63 Million | 10.63 Million | 9.54 Million | 10.01 Million | 10.17 Million | 10.16 Million |
Weighted Average Shares Outstanding (Diluted) | 11.06 Million | 11.05 Million | 9.79 Million | 10.01 Million | 10.18 Million | 10.17 Million |
Gross Margin | 0.17 | 0.16 | 0.14 | 0.14 | 0.13 | 0.13 |
EBIT Margin | 0.08 | 0.09 | 0.09 | 0.04 | 0.04 | 0.07 |
Profit Margin | -0.00 | 0.02 | 0.02 | -0.05 | -0.02 | 0.03 |
EBITDA | 1.11 Billion | 1.36 Billion | 1.01 Billion | 1.07 Billion | 517 Million | 997 Million |
Earnings Before Tax Margin | 0.04 | 0.05 | 0.04 | -0.04 | -0.01 | 0.05 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 3.05 Billion | 2.99 Billion | 13.28 Billion | 3.06 Billion | 3.63 Billion | 3.2 Billion |
Cost of Revenue | 2.44 Billion | 2.39 Billion | 10.97 Billion | 2.54 Billion | 3 Billion | 2.61 Billion |
Gross Profit | 610 Million | 603 Million | 2.31 Billion | 521 Million | 621 Million | 586 Million |
Operating Expenses | 267 Million | 340 Million | 1.78 Billion | 481 Million | 448 Million | 427 Million |
Selling, General and Administrative Expenses | 440 Million | 443 Million | - | -903 Million | 450 Million | 429 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -173 Million | - | 22 Million | - | - | - |
Cost and Expenses | 2.71 Billion | 2.73 Billion | 12.75 Billion | 3.02 Billion | 3.45 Billion | 3.04 Billion |
Operating Income | 343 Million | 263 Million | 589 Million | 96 Million | 173 Million | 159 Million |
Interest Expense | 75 Million | 54 Million | 228 Million | 38 Million | 58 Million | 64 Million |
Income Tax Expense | 37 Million | 31 Million | 71 Million | 1 Million | 19 Million | 25 Million |
Earnings before Tax | 285 Million | 231 Million | 404 Million | 64 Million | 127 Million | 102 Million |
Net Income | 248 Million | 200 Million | -5 Million | 63 Million | -238 Million | 85 Million |
Earnings Per Share Basic | 23.20 | 18.80 | - | 5.92 | -22.38 | 8.00 |
Earnings Per Share Diluted | 22.70 | 18.20 | - | 5.70 | -22.30 | 7.70 |
Weighted Average Shares Outstanding | 10.68 Million | 10.63 Million | 10.63 Million | 11.04 Million | 10.63 Million | 10.62 Million |
Weighted Average Shares Outstanding (Diluted) | 10.92 Million | 10.98 Million | 11.06 Million | 11.07 Million | 10.67 Million | 11.03 Million |
Gross Margin | 0.20 | 0.20 | 0.17 | 0.17 | 0.17 | 0.18 |
EBIT Margin | 0.16 | 0.14 | - | 0.03 | 0.12 | 0.09 |
Profit Margin | 0.08 | 0.07 | -0.00 | 0.02 | -0.07 | 0.03 |
EBITDA | 484 Million | 406 Million | - | 102 Million | 444 Million | 282 Million |
Earnings Before Tax Margin | 0.11 | 0.09 | 0.04 | 0.03 | 0.05 | 0.05 |
KALYANCAP
BIOL
1072
ACTIVE
EQTRF
9435